Literature DB >> 21778213

Early-elective single-incision laparoscopic sigmoidectomy for perforated diverticulitis using a totally reusable single-port device.

Joachim Reibetanz1, Alexander Kerscher, Mia Kim, Alexander Wierlemann, Christoph-Thomas Germer, Katica Krajinovic.   

Abstract

BACKGROUND: Single-port access (SPA) is an emerging concept in minimally invasive colorectal surgery. The authors report their experience using SPA sigmoidectomy as an early-elective approach to complicated diverticulitis with paracolic abscess.
METHODS: Between September 2009 und April 2010, 4 patients underwent SPA sigmoidectomy for Hinchey-I diverticulitis using the reusable X-Cone device.
RESULTS: After a median time of antibiotic treatment of 8 days, SPA sigmoidectomy was performed successfully in all patients. The median operative time was 200 minutes (range, 187-221 minutes). No intraoperative or postoperative complications were recorded; the median postoperative hospital stay was 7 days (range, 5-7 days). No incisional hernias were observed at midterm follow-up (median, 11.5 months; range, 8-14 months).
CONCLUSIONS: When performed by an experienced laparoscopic surgeon, early-elective SPA sigmoidectomy is a feasible and safe approach to complicated diverticulitis. The reusability of the X-Cone device ensures that the costs of the procedure are not high.

Entities:  

Mesh:

Year:  2011        PMID: 21778213     DOI: 10.1177/1553350611413610

Source DB:  PubMed          Journal:  Surg Innov        ISSN: 1553-3506            Impact factor:   2.058


  2 in total

Review 1.  Minimally invasive surgical treatment of sigmoid diverticulitis.

Authors:  B D Barry; J Leroy; D Mutter; H-S Wu; J Marescaux
Journal:  Langenbecks Arch Surg       Date:  2012-05-31       Impact factor: 3.445

2.  Laparoendoscopic single-site (LESS) varicocelectomy with reusable components: comparison with the conventional laparoscopic technique.

Authors:  Frank Friedersdorff; Seven Johannes Aghdassi; Peter Werthemann; Hannes Cash; Irena Goranova; Jonas Felix Busch; Jan Ebbing; Stefan Hinz; Kurt Miller; Joerg Neymeyer; Tom Florian Fuller
Journal:  Surg Endosc       Date:  2013-04-03       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.